Precision Therapeutics (NASDAQ:AIPT) Releases Quarterly Earnings Results

Precision Therapeutics (NASDAQ:AIPT) issued its quarterly earnings data on Monday, April 1st. The medical instruments supplier reported ($0.24) earnings per share for the quarter, Morningstar.com reports. The firm had revenue of $0.31 million for the quarter. Precision Therapeutics had a negative return on equity of 346.59% and a negative net margin of 713.80%.

Shares of AIPT traded down $0.02 during mid-day trading on Wednesday, hitting $0.72. 24,300 shares of the company traded hands, compared to its average volume of 91,762. Precision Therapeutics has a one year low of $0.60 and a one year high of $1.58.

WARNING: This article was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/04/24/precision-therapeutics-aipt-releases-quarterly-earnings-results.html.

Precision Therapeutics Company Profile

Precision Therapeutics Inc provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables.

Featured Article: What is the float in trading stocks?

Earnings History for Precision Therapeutics (NASDAQ:AIPT)

Receive News & Ratings for Precision Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.